A diabetes startup that uses artificial intelligence, Bigfoot Biomedical, has just announced that it scored a total of $55 million in Series B equity financing with new investments from Abbott and other existing funders.
from MobiHealthNews https://ift.tt/2GgMJgt
March 28, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Glucose monitor maker Intuity Medical brings in $40MFremont, California-based Intuity Medical, a diabetes management technology company, announced that it will be receiving $40 million in equity financing from several of its previous investors, including Accuitive Medical Vent… Read More
Healthcare cost, quality transparency company Amino launches its own HSA, debit cardSan Francisco-based Amino, which has offered a consumer-facing cost and quality transparency tool since 2015, is launching a new offering: its own Health Savings Account (HSA) and debit card. from MobiHealthNews http://ift.t… Read More
American Well lands $59.2M strategic investment from insurer Allianz, partners with PhilipsBoston-based telemedicine provider American Well announced today that it landed $59.2 million in funding from insurer and asset manager Allianz Group's digital investment unit, Allianz X. from MobiHealthNews http://ift… Read More
HIMSS18 Patient Engagement and Experience Summit: New strategies for precision medicine, telehealth, social determinantsLots of health systems pay lip service to patient-centric care, but what does that really mean? As healthcare continues its transition to paying for value and outcomes, toward managing wellness rather than treating disease, m… Read More
Fitbit invests $6M in glucose monitoring startup SanoFitbit has recently invested $6 million in San Fransisco-based Sano, a company developing a mobile app and sensor that will allow users to continuously monitor blood glucose levels, multiple publications have confirmed. … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment